Related Experiment Video
Updated: Feb 15, 2026

A User-friendly and Powerful R Analysis of Large-scale Datasets
Published on: November 4, 2025
A User-Friendly App for Blood Coagulation Disorders
1Appamedix, Innovations-Centrum CHIC, Berlin, Germany. jv@appamedix.com.
Insights
Maternal environment impacts offspring health, increasing risks for diseases like type 2 diabetes. This study introduces a test strip and app for patients to self-manage blood coagulation activity and monitor treatment effects.
Area of Science:
- Biomedical science
- Health technology
- Patient self-management
Background:
- Suboptimal maternal environment linked to offspring's age-associated diseases (type 2 diabetes, obesity, cardiovascular disease).
- Altered blood clotting time is a factor in these diseases and requires monitoring in specific patient groups.
- Coagulant medication management is crucial for patients with cardiovascular disorders and post-surgery.
Purpose of the Study:
- To describe a method for patient self-management of blood coagulation activity.
- To introduce a test strip device and accompanying mobile application (Coagu app) for this purpose.
- To highlight the app's utility in treatment monitoring and adherence.
Main Methods:
- Utilizes a test strip device for measuring blood coagulation activity.
- Employs the Coagu app for data logging and analysis.
- The app serves as a tool for treatment reminders and long-term effect monitoring.
Main Results:
- Enables patients to actively participate in managing their blood coagulation.
- Provides a convenient method for tracking treatment efficacy over time.
- Facilitates timely adherence to medication schedules.
Conclusions:
- Patient self-management of blood coagulation is feasible with the described technology.
- The Coagu app supports treatment adherence and monitoring, potentially improving outcomes for individuals at risk of or with age-associated diseases.
- This approach empowers patients in managing conditions affected by blood clotting time.
Abstract:
There is a strong association between a suboptimal maternal environment and increased risk of developing age-associated diseases such as type 2 diabetes, obesity, and cardiovascular disease in the offspring. Blood clotting time may be altered in all of these conditions, and it is also an important factor that requires monitoring in postoperative and cardiovascular disorder patients who are on coagulant medications. This chapter describes patient self-management of blood coagulation activity using a test strip device and the Coagu app. The app can also be used as a reminder of treatment times and for monitoring the effects of treatment over time.
Related Concept Videos
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Intrinsically Disordered Proteins
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

